GettyImages

A medical diagnostics technology company

About Rhythm Biosciences

Rhythm Biosciences (ASY:RHY) is transforming cancer diagnostics through innovative diagnostic technologies that predict, detect, characterise, and support early intervention. Our mission goes beyond testing, we're creating a comprehensive approach to understanding cancer risk, enabling earlier treatment, and ultimately saving lives.

Unlike traditional screening methods that are invasive, uncomfortable, and often avoided, we’re developing precise and accessible screening solutions, that empower patients and healthcare systems with critical insights. 

Rhythm is not just a medical technology company, we’re health innovators driven by a singular purpose. Our work is about knowledge, reducing unnecessary medical procedures, alleviating the strain on healthcare systems, and most importantly, giving people the earliest possible chance to take control of their health. 

Rhythm is building a future where cancer is identified early and treated effectively. 

Vision 

To be a pioneering force in early cancer detection through innovative, accessible, and accurate diagnostic technologies that: 

  • Improve patient outcomes and potentially save lives
  • Identify risk for the personalised management of health
  • Simplify cancer screening processes
  • Reduce healthcare costs

We are transforming cancer detection and management through: 

  • Risk assessment – Identifying an individual’s likelihood of developing specific cancers through advanced genetic and clinical analysis
  • Early detection – Finding cancer at its earliest, most treatable stages using innovative non-invasive diagnostics
  • Characterisation – Understanding the specific nature and behaviour of detected cancers through detailed molecular analysis to determine cancer type, severity, and optimal treatment approaches.
  • Treatment support – Providing ongoing diagnostic insights that help clinicians monitor treatment effectiveness and make informed decisions about patient care plans

Our Mission

Rhythm Biosciences is committed to saving lives through early detection of cancers using simple and accurate diagnostic technology

Pipeline

Leveraging the proprietary immunoassay, developed for our ColoSTAT® blood test, Rhythm Biosciences is investigating the feasibility of using this technology to establish diagnostic tests for detection of other cancer types. Our combined platforms support a highly comprehensive approach to cancer diagnostics which addresses a huge total available market.



RHYTHM BIOSCIENCES

Contact

Rhythm Biosciences

Bio21 Institute
30 Flemington Road
Parkville VIC 3010
Australia

Keep up to date:

Connect with us:


JOIN OUR
MAILING LIST